MA23683A1 - Derives de cycloalkanoindoles et de cycloalcanoazaindoles - Google Patents

Derives de cycloalkanoindoles et de cycloalcanoazaindoles

Info

Publication number: MA23683A1
Authority: MA; Morocco
Prior art keywords: opt; substd; alkyl; phenyl; alkoxy
Prior art date: 1994-10-04

Application number

MA24027A

Other languages

English (en)

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

1995-10-02

Publication date

1996-07-01

1995-10-02 Application filed by Bayer Ag filed Critical Bayer Ag

1996-07-01 Publication of MA23683A1 publication Critical patent/MA23683A1/fr

Links

125000000217 alkyl group Chemical group 0.000 abstract 9
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
125000002252 acyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 3
125000005843 halogen group Chemical group 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
150000001925 cycloalkenes Chemical class 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

MA24027A 1994-10-04 1995-10-02 Derives de cycloalkanoindoles et de cycloalcanoazaindoles MA23683A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (1)

Publication Number	Publication Date
MA23683A1 true MA23683A1 (fr)	1996-07-01

Family

ID=6529939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24027A MA23683A1 (fr)	1994-10-04	1995-10-02	Derives de cycloalkanoindoles et de cycloalcanoazaindoles

Country Status (35)

Country	Link
US (6)	US5684014A (fr)
EP (1)	EP0705831B1 (fr)
JP (1)	JP3901234B2 (fr)
KR (1)	KR100355986B1 (fr)
CN (2)	CN1050605C (fr)
AT (1)	ATE255580T1 (fr)
AU (1)	AU700609B2 (fr)
CA (1)	CA2159546C (fr)
CZ (1)	CZ291348B6 (fr)
DE (2)	DE4435477A1 (fr)
DK (1)	DK0705831T3 (fr)
DZ (1)	DZ1934A1 (fr)
EE (1)	EE03527B1 (fr)
ES (1)	ES2211890T3 (fr)
FI (2)	FI113048B (fr)
HN (1)	HN1995009160A (fr)
HR (1)	HRP950505B1 (fr)
HU (1)	HU225052B1 (fr)
IL (3)	IL129641A (fr)
MA (1)	MA23683A1 (fr)
MY (1)	MY117282A (fr)
NO (1)	NO305365B1 (fr)
NZ (1)	NZ280130A (fr)
PH (1)	PH31400A (fr)
PL (1)	PL183154B1 (fr)
PT (1)	PT705831E (fr)
RU (1)	RU2157803C2 (fr)
SG (1)	SG63528A1 (fr)
SI (1)	SI0705831T1 (fr)
SK (1)	SK284260B6 (fr)
SV (1)	SV1995000062A (fr)
TN (1)	TNSN95098A1 (fr)
TW (1)	TW448175B (fr)
UA (1)	UA44700C2 (fr)
ZA (1)	ZA958297B (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
EP0802192A1 (fr) *	1996-04-17	1997-10-22	Bayer Ag	Phénylglycinamides d'acides hétérocycliques substitués ayant une activité antiathéroschlérotique et procédé pour leur préparation
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
SK16332000A3 (sk) *	1998-05-01	2001-06-11	Eli Lilly And Company	Ester ako inhibítor spla2
ATE258934T1 (de) *	1998-10-30	2004-02-15	Lilly Co Eli	Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
WO2000071502A1 (fr) *	1999-05-25	2000-11-30	Yamanouchi Pharmaceutical Co., Ltd.	Derives d'hydrazide
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
KR100826817B1 (ko) *	2000-03-15	2008-05-02	사노피-아벤티스 도이칠란트 게엠베하	치환된 베타-카볼린
EP1134221A1 (fr) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Bêta-carbolines substituées comme inhibiteurs de lkB kinase
WO2001074817A1 (fr) *	2000-03-30	2001-10-11	Yamanouchi Pharmaceutical Co., Ltd.	Derives d'hydrazide
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
CZ20032341A3 (cs) *	2001-01-31	2004-12-15	Synaptic Pharmaceutical Corporation	Použití antagonistů GAL3 receptoru pro léčbu deprese a/nebo úzkosti
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
CN101838218A (zh) *	2002-02-28	2010-09-22	日本烟草产业株式会社	酯化合物及其医药用途
MXPA04011930A (es) *	2002-05-31	2005-03-31	Yamanouchi Pharma Co Ltd	Derivados de tetrahidropirano.
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
WO2004063156A1 (fr) *	2003-01-08	2004-07-29	Biovitrum Ab	Nouveaux derives d'indole utiles comme inhibiteurs de fabp-4
WO2005051382A1 (fr) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	Agent renforçant l'effet hypolipidemiant
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
CA2910191C (fr)	2004-03-05	2022-03-08	The Trustees Of The Univeristy Of Pennsylvania	L'utilisation d'inhibiteurs mtp pour le traitement a faibles effets secondaires contre des affections liees a l'hyperlipidemie et l'hypercholesterolemie
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
US20080280922A1 (en) *	2004-04-09	2008-11-13	Marc Alois Celine Maria Engelen	Intermittent Dosing Regimen For Overweight and Obese Subjects
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
EP1806149A4 (fr) *	2004-10-25	2012-12-05	Japan Tobacco Inc	Préparation médicinale solide améliorée en termes de solubilité et de stabilité et procédé servant à produire celle-ci
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
EP1890767A2 (fr) *	2005-05-27	2008-02-27	Pfizer Products Inc.	Combinaison d'un antagoniste des recepteurs cannabinoides-1 et d'un inhibiteur des proteines microsomales de transfert de triglycerides pour traiter l'obesite ou maintenir une perte de poids
EP1912968A1 (fr) *	2005-08-04	2008-04-23	Pfizer Limited	Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
CA2626441A1 (fr) *	2005-10-18	2007-04-26	Aegerion Pharmaceuticals	Methodes permettant de traiter les troubles associes a l'hyperlipidemie chez un mammifere
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
CA2642922C (fr) *	2006-02-23	2011-08-02	Pfizer Limited	Piperidinoylpyrrolidines en tant qu'agonistes du recepteur de la melanocortine de type 4
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
EP2040704A2 (fr) *	2006-05-18	2009-04-01	Bayer Healthcare Ag	Compositions pharmaceutiques contenant du implitapide et leurs méthodes d'application
JP2010509392A (ja)	2006-11-13	2010-03-25	ファイザー・プロダクツ・インク	ジアリール、ジピリジニルおよびアリール−ピリジニル誘導体ならびにその使用
US8404896B2 (en)	2006-12-01	2013-03-26	Bristol-Myers Squibb Company	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20080161279A1 (en) *	2006-12-21	2008-07-03	Wisler Gerald L	Methods of Treating Obesity
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (fr) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Méthodes de traitement de l'hépatite c
US8592403B2 (en) *	2008-08-06	2013-11-26	Pfizer Limited	Diazepine and diazocane compounds as MC4 agonists
CN105120863B (zh)	2013-03-14	2021-06-04	奥斯特克有限公司	促进骨生长的烷基胺骆驼蓬碱衍生物
WO2016037106A1 (fr) *	2014-09-05	2016-03-10	Allosteros Therapeutics, Inc	Inhibiteurs camkii et leurs utilisations
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560B (zh)	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
ES3004565T3 (en)	2018-08-14	2025-03-12	Ossifi Therapeutics Llc	Pyrrolo - dipyridine compounds for the treatment of bone loss
CN113166058A (zh)	2018-08-14	2021-07-23	奥斯特克有限公司	氟β-咔啉化合物
CA3186856A1 (fr)	2020-07-29	2022-02-03	Ruth NALLEN	Lomitapide destine a etre utilise dans des methodes de traitement de l'hyperlipidemie et de l'hypercholesterolemie chez des patients pediatriques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
IL81325A (en) *	1986-01-23	1990-11-29	Merck Frosst Canada Inc	Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1326030C (fr) *	1987-07-21	1994-01-11	John W. Gillard	Acides cyclohept[b]indole alcanoiques
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 EP EP95114877A patent/EP0705831B1/fr not_active Expired - Lifetime
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-09-29 CA CA2159546A patent/CA2159546C/fr not_active Expired - Fee Related
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active Expired - Fee Related
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 EE EE9500071A patent/EE03527B1/xx not_active IP Right Cessation
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL129641A (en)	2000-08-31
DK0705831T3 (da)	2004-04-05
CN1183111C (zh)	2005-01-05
US6265431B1 (en)	2001-07-24
UA44700C2 (uk)	2002-03-15
ES2211890T3 (es)	2004-07-16
NO953930L (no)	1996-04-09
CZ256795A3 (en)	1996-04-17
NO305365B1 (no)	1999-05-18
TNSN95098A1 (fr)	1996-02-06
FI20002693L (fi)	2000-12-08
KR960014126A (ko)	1996-05-22
FI113048B (fi)	2004-02-27
PH31400A (en)	1998-10-29
EE03527B1 (et)	2001-10-15
SI0705831T1 (en)	2004-02-29
HRP950505A2 (en)	1997-08-31
PT705831E (pt)	2004-04-30
CN1050605C (zh)	2000-03-22
IL115493A0 (en)	1996-01-19
DE59510839D1 (de)	2004-01-15
HRP950505B1 (en)	2002-04-30
US6479503B2 (en)	2002-11-12
HU9502891D0 (en)	1995-11-28
ATE255580T1 (de)	2003-12-15
PL310756A1 (en)	1996-04-15
JP3901234B2 (ja)	2007-04-04
CN1224715A (zh)	1999-08-04
TW448175B (en)	2001-08-01
SK123995A3 (en)	1996-06-05
CA2159546C (fr)	2010-12-14
HK1005139A1 (en)	1998-12-24
ZA958297B (en)	1996-05-06
NZ280130A (en)	1996-05-28
US6858622B2 (en)	2005-02-22
US20020147209A1 (en)	2002-10-10
JPH08225526A (ja)	1996-09-03
US5684014A (en)	1997-11-04
SV1995000062A (es)	1996-07-10
US6245775B1 (en)	2001-06-12
CN1130631A (zh)	1996-09-11
FI954681A0 (fi)	1995-10-02
EE9500071A (et)	1996-04-15
US20030149073A1 (en)	2003-08-07
FI954681A7 (fi)	1996-04-05
SK284260B6 (sk)	2004-12-01
EP0705831A2 (fr)	1996-04-10
MY117282A (en)	2004-06-30
PL183154B1 (pl)	2002-05-31
NO953930D0 (no)	1995-10-03
FI108791B (fi)	2002-03-28
KR100355986B1 (ko)	2003-01-06
HUT73240A (en)	1996-07-29
CZ291348B6 (cs)	2003-02-12
EP0705831A3 (fr)	1997-01-22
US20020055635A1 (en)	2002-05-09
HN1995009160A (es)	2000-04-24
EP0705831B1 (fr)	2003-12-03
AU700609B2 (en)	1999-01-07
AU3292095A (en)	1996-04-18
RU2157803C2 (ru)	2000-10-20
IL115493A (en)	1999-10-28
IL129641A0 (en)	2000-02-29
DZ1934A1 (fr)	2002-02-17
SG63528A1 (en)	1999-03-30
CA2159546A1 (fr)	1996-04-05
HU225052B1 (en)	2006-05-29
DE4435477A1 (de)	1996-04-11

Publication	Publication Date	Title
MA23683A1 (fr)	1996-07-01	Derives de cycloalkanoindoles et de cycloalcanoazaindoles
ATE204269T1 (de)	2001-09-15	Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AU2819992A (en)	1993-05-13	Hiv protease inhibitors useful for the treatment of aids
FR2619111B1 (fr)	1991-01-11	Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
PL310460A1 (en)	1996-03-18	Novel derivatives of imidazopyridine, method of obtaining them and drugs containing such derivatives
HU9600914D0 (en)	1996-05-28	4-indolylpiperazinyl derivatives
ATE197794T1 (de)	2000-12-15	Benzyloxy-substituierte phenylglycinolamide als arzneimittel
NO963374D0 (no)	1996-08-13	Substituerte 4H-pyraner
ATE186536T1 (de)	1999-11-15	Verwendung von 1,2-überbrückten 1,4- dihydropyridinen als selektive kaliumkanalmodulatoren
HUP9602636A2 (hu)	1998-11-30	Amino-kinazolinon- és amino-kinazolintion-származékok, intermedierjeik, valamint ezeket a vegyületeket hatóanyagként tartalmazó peszticid készítmények és eljárás alkalmazásukra